Journal
British Journal of Cancer
Publication Date
2009
Volume
101
Issue
9
Inclusive Pages
1543-1548
Document Type
Open Access Publication
DOI
10.1038/sj.bjc.6605346
Rights and Permissions
S Novello, et al. Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer. British Journal of Cancer (2009) 101, 1543–1548. doi:10.1038/sj.bjc.6605346 www.bjcancer.com Copyright 2009 Cancer Research UK From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ 16 November 2011 This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Recommended Citation
Novello, Silvia; Scagliotti, Giorgio V.; Rosell, Rafael C.; Socinski, Mark A.; Brahmer, Julie R.; Atkins, James N.; Palleres, Cinta; Burgess, Russell E.; Tye, Lesley; Selaru, Paulina; Wang, Erjian; Chao, Richard; and Govindan, Ramaswamy, "Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer." British Journal of Cancer. 101, 9. 1543-1548. (2009).
https://digitalcommons.wustl.edu/open_access_pubs/4069
